Alpha 2.0
Login Register
» Articles » PMID: 12963934

Intravenous Immunoglobulin in Livedo Vasculitis: a New Treatment Option?

Overview
Journal J Am Acad Dermatol
Specialty Dermatology
Date 2003 Sep 10
PMID 12963934
Citations 6
Authors
Stefan Schanz
Anja Ulmer
Gerhard Fierlbeck
Affiliations
Soon will be listed here.
Citing Articles

Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review.

Gao Y, Jin H Ther Adv Chronic Dis. 2022; 13:20406223221097331.

PMID: 35634570 PMC: 9134453. DOI: 10.1177/20406223221097331.

Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level.

Kofler K, Strolin A, Geiger V, Kofler L J Cutan Med Surg. 2021; 25(5):504-510.

PMID: 33779349 PMC: 8474298. DOI: 10.1177/12034754211003525.

Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses.

Scarpone R, Meier K, Ghoreschi K, Worm M Acta Derm Venereol. 2020; 100(17):adv00298.

PMID: 33047147 PMC: 9274976. DOI: 10.2340/00015555-3662.

[Skin diseases due to systemic vasculitides and vasculopathies].

Volc S, Maier J, Rocken M Hautarzt. 2016; 67(12):948-959.

PMID: 27864582 DOI: 10.1007/s00105-016-3896-x.

Livedoid thrombotic vasculopathy responding to doxycycline therapy.

Keller M, Lee J, Webster G J Clin Aesthet Dermatol. 2011; 1(4):22-4.

PMID: 21212844 PMC: 3016933.